Fitbit’s upcoming Sense smartwatch is its most advanced health tracker yet. And this statement got stronger, like the company has received FDA clearance to activate its electrocardiogram (ECG) heart monitor app even before the watch releases.
A smartwatch EKG monitor monitors your heart rate and looks for signs of atrial fibrillation (atrial fibrillation), which is the most common type of irregular heartbeat. Due to the implications of health tracking, companies need FDA clearance before they can offer the feature to users.
“Helping people understand and manage their heart health has always been a priority for Fitbit, and our new ECG app is designed for users who want to check themselves in the moment and review the reading later with their doctor,” said said Eric Friedman, Fitbit co-founder and CTO. “Early detection of atrial fibrillation is essential, and I am extremely excited that we are making these innovations available to people around the world to help them improve their heart health, prevent more serious disease and potentially save lives.”
Atrial fibrillation can be difficult to detect and puts people at an increased risk for stroke. Often, people don’t realize they had atrial fibrillation before a stroke. Early detection can lead to better health outcomes, after all.
The Fitbit Sense marks the third smartwatch with an app authorized for the use of the EKG, after the Apple Watch and Samsung. The clearance comes just in time for Fitbit to launch the new device with the feature enabled, something Samsung failed to achieve with the Galaxy Active2.